AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351 (k) biosimilar pathway, today announced that ...
Urgent recall of popular garlic bread over health risk fears
If your food was affected, do not eat it - instead, Birds Eye has asked customers to return the packaging to the shop where ...